Phenytoin
USP/1535008 - United States Pharmacopeia (USP) Reference Standard
Synonym: 5,5-
CAS Number: 57-41-0
Empirical Formula (Hill Notation): C15H12N2O2
Molecular Weight: 252.27
MDL Number: MFCD00005264
Linear Formula: C15H12N2O2
Product Type: Chemical
API family | phenytoin |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C15H12N2O2/c18-13-15(1 |
InChI key | CXOFVDLJLONNDW-UHFFFAOYSA |
manufacturer/tradename | USP |
mp | 293-295 °C (lit.) |
SMILES string | O=C1NC(=O)C(N1)(c2ccccc2) |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Phenytoin USP Reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monographs such as: • Phenytoin Sodium • Phenytoin Chewable Tablets • Phenytoin Oral Suspension • Phenytoin Sodium Injection • Extended Phenytoin Sodium Capsules • Phenytoin Compounded Topical Gel • Fosphenytoin Sodium Injection |
Biochem/physiol Actions: | Reduces incidence of grand mal seizures; appears to stabilize excitable membranes perhaps through effects on Na+, K+, and Ca2+ channels. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS07,GHS08 |
Signal word | Danger |
Hazard statements | H302 - H351 - H360FD |
Precautionary statements | P202 - P264 - P270 - P280 - P301 + P312 - P308 + P313 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
mp | 293-295 °C (lit.) |
UNSPSC | 41116107 |